Early Treatment for Smoldering Multiple Myeloma
Identifying patients with smoldering myeloma at high risk for disease progression may allow for implementation of better treatment strategies.
Identifying patients with smoldering myeloma at high risk for disease progression may allow for implementation of better treatment strategies.
Integrating mutation-specific data across repositories and portals may lead to novel therapeutically actionable insights for acute myeloid leukemia.
For patients with low-risk thyroid cancer, ablation when indicated could be achieved with 1.1 GBq radioactive iodine after recombinant human thyroid-stimulating hormone (rhTSH) injections, as this combination reduces whole body irradiation and maintains quality of life.